Last reviewed · How we verify
NCT05297604
Non-Invasive Intravascular Laser Irradiation Of Blood In The Treatment Of Children With Temporomandibular Disorders
NA trial testing Vascular photobiomodulation (VPBM) in Temporomandibular Disorder in 56 participants. Completed in 10 November 2023.
20 June 2023
Quick facts
| Lead sponsor | University of Nove de Julho |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 56 |
| Start date | 20 October 2022 |
| Primary completion | 20 June 2023 |
| Estimated completion | 10 November 2023 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Vascular photobiomodulation (VPBM)
- Sham group (simulated vascular photobiomodulation)
Conditions studied
- Temporomandibular Disorder — all drugs for Temporomandibular Disorder →
Sponsor
University of Nove de Julho
Who can join
Adults 6 to 9, any sex, with Temporomandibular Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is blind, randomized controlled and have been carried out on children between 6 and 9 years of age, at the Catholic University of Uruguay, Faculty of Health Sciences, Postgraduate School, and surrounding schools. Patients who present temporomandibular disorders, based on the diagnostic criteria will be the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) were included. The laser used was infrared, power 100 mW ±20%, wavelength 660nm ±10 nm, energy parameter 60J, continuous application. The technique is not invasive, the irradiation point is by continuous and direct transcutaneous application to the radial artery by means of a bracelet that inserts the laser beam. One session has been performed. There was a laser group, a placebo group. Participants in all groups were re-evaluated after the procedure, following the same evaluation procedures used initially, evaluating the effects of ILIB on pain and range of motion.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Vascular photobiomodulation in the treatment of children with temporomandibular disorders: Study protocol for a randomized, controlled, blind, clinical trial.
Sertaje MRF, Gonçalves MLL, Gomes AO, Bruno LH, et al · · 2022 · cited 3× · PMID 36281107 · DOI 10.1097/md.0000000000031228
Verify or expand the search:
- PubMed search for NCT05297604
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorder
Currently open trials in the same condition.
- NCT06941636 — Botulinumtoxin A as a Treatment for Myalgia and Myofacial Pain in Patient With Temporomandibulardisorders · Phase 3 · recruiting
- NCT03849534 — Treatment of Temporomandibular Disorders in Children and Adolsecents · NA · recruiting
- NCT06214923 — Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) · NA · recruiting
- NCT06365151 — An Algorithm for Approaching Temporomandibular Disorders With Osteopathic Manual Therapy in Patients With Fibromyalgia · NA · recruiting
- NCT06357702 — K23- Physical Self Regulation vs Placebo · NA · recruiting
Other University of Nove de Julho trials
Trials by the same sponsor.
- NCT07501143 — Effects of Physical Training in Patients With Advanced Heart Failure · NA · not yet recruiting
- NCT07525310 — Photobiomodulation Effects on Blood Pressure and Vascular Function in Treated Hypertensive Patients · NA · not yet recruiting
- NCT06984796 — Photobiomodulation on Pain Perception During the Insertion of the T 380 Copper Intrauterine Device (IUD) · NA · not yet recruiting
- NCT07302204 — Efficacy of Aerobic Exercise Versus Therapeutic Exercises on Exercise-induced Hypoalgesia in Knee Osteoarthritis · NA · recruiting
- NCT07033039 — Effects of Red and Infrared Photobiomodulation in Rhinoplasty at a Single Centre · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05297604 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Nove de Julho
- Last refreshed: 21 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297604.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing